Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema

NCT05728476 is registered in ClinicalTrials.gov with Tianjin Medical University Eye Hospital as lead sponsor.

NCT NCT05728476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05728476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema
Lead sponsor
Tianjin Medical University Eye Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 5, 2024
Completion date
September 5, 2026
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

conbercept, diabetic macular edema, pars plana vitrectomy